Physical Intimacy of Breast Cancer Cells with Mesenchymal Stem Cells Elicits Trastuzumab Resistance through Src Activation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep13744.pdf
Reference51 articles.
1. Krishnamurti, U. & Silverman, J. F. HER2 in breast cancer: a review and update. Adv Anat Pathol 21, 100–107 (2014).
2. Subbiah, I. M. & Gonzalez-Angulo, A. M. Advances and future directions in the targeting of HER2-positive breast cancer: implications for the future. Curr Treat Options Oncol 15, 41–54 (2014).
3. Bailey, T. A. et al. Mechanisms of Trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance. Journal of carcinogenesis 10, 28, 10.4103/1477-3163.90442 (2011).
4. Garrett, J. T. & Arteaga, C. L. Resistance to HER2-directed antibodies and tyrosine kinase inhibitors: mechanisms and clinical implications. Cancer biology & therapy 11, 793–800 (2011).
5. Fiszman, G. L. & Jasnis, M. A. Molecular Mechanisms of Trastuzumab Resistance in HER2 Overexpressing Breast Cancer. International journal of breast cancer 2011, 352182, 10.4061/2011/352182 (2011).
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Signaling crosstalk between mesenchymal stem cells and tumor cells: Implications for tumor suppression or progression;Cytokine & Growth Factor Reviews;2024-04
2. The cellular composition of the tumor microenvironment is an important marker for predicting therapeutic efficacy in breast cancer;Frontiers in Immunology;2024-02-29
3. A hybrid breast cancer/mesenchymal stem cell population enhances chemoresistance and metastasis;JCI Insight;2023-09-22
4. Multi compartmental 3D breast cancer disease model–recapitulating tumor complexity in in-vitro;Biochimica et Biophysica Acta (BBA) - General Subjects;2023-06
5. Fibroblasts as Turned Agents in Cancer Progression;Cancers;2023-03-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3